Companies / BOC Sciences / Vofatamab
BOC Sciences

Vofatamab | BOC Sciences

Vofatamab is a human monoclonal antibody directed against FGFR3 that blocks activation of both the wildtype and genetically activated receptor. In combination with pembrolizumab, vofatamab is used in the research of metastatic urothelial carcinoma (mUC).

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.